Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Canine Blood Biomarkers Indicate Septic Infection in Humans Too

By LabMedica International staff writers
Posted on 22 Dec 2011
The amount of certain blood biomarkers is a good indication of infection in dogs, and the same would hold true in humans suffering from similar conditions. More...


In pets and people, the time it takes to diagnose an infection may mean life or death, and identifying ways to diagnose pet infections in approximately a third of the current diagnosis time could be used eventually for humans.

Veterinarians at the University of Missouri (Columbia, MO, USA) tested several biomarkers for infection in dogs. They found that found that measuring the amount of the blood biomarker N-terminal portion of pro C-type natriuretic peptide (NT-pCNP) is a good indication of infection, and the same could be applied in humans. In one study, the NT-pCNP assay was performed by a sandwich enzyme-linked immunoassay (ELISA), (Biomedica Medizinprodukte GmbH & Co KG, Vienna, Austria). This ELISA utilizes a highly purified polyclonal sheep antibody directed against amino acids 1-19 and 30-50 of human NT-pCNP that is 96% homologous with canine pCNP.

In a separate study plasma samples obtained from both septic and normal control groups were used for determination of the nitric oxide end products nitrate (NO3–) and nitrite (NO2–) using a commercially available kit , the Parameter Total Nitric Oxide and Nitrite/Nitrate Assay; (R&D Systems, Minneapolis, MN, USA). This two-step assay utilizes nitrate reductase to convert nitrate to nitrite and then detects total nitrite using the Greiss reaction to produce an azo dye compound. The range of detection of this assay is 3.12-200 µmol/L.

Plasma total nitrate/nitrite was significantly greater in the sepsis group compared with the control group and a systemic inflammatory response syndrome (SIRS) group. Serum NT-pCNP concentration was significantly greater in the sepsis group (median, 11 pmol/L) compared with the noninfectious forms of SIRS (5.2 pmol/L); and healthy control groups (6.4 pmol/L). Amy DeClue, DVM, assistant professor of veterinary internal medicine, said, "My group has been evaluating different blood biomarkers that could give a quick and accurate indication of infection, and we believe we've found a biomarker that will only require a simple blood test. The systems in dogs and people are very applicable to each other, so whatever biomarkers we find in dogs could also benefit people."

The scientists hope to develop a portable bedside test that veterinarians could use to quickly test patients for infection and ultimately target a better cure. The NT-pCNP biomarker study was published in the May/June 2011 issue of Journal of Veterinary Internal Medicine and the plasma nitrate/nitrite study was published online on September 9, 2011, in the journal Veterinary Record.

Related Links:
University of Missouri
Biomedica Medizinprodukte
R&D Systems



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.